AMR KAHF: Open Payments
NPI 1326257668 · HALEDON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 74 payments from 17 companies in 2025. Trend: 2023 $1,369 · 2024 $1,036 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $201 |
| Lilly USA, LLC | 10 | $170 |
| ABBVIE INC. | 14 | $157 |
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| Gilead Sciences, Inc. | 4 | $76 |
| Exact Sciences Corporation | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Medtronic, Inc. | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
Products named: AUSTEDO XR, FARXIGA, MOUNJARO, Cologuard Collection Kit, JARDIANCE, CREON, LINZESS, REXULTI.
Industry payments across NJ — which companies pay providers there.
